Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 17
SponsorHemoSonics LLC

About this trial

This study will determine reference range intervals for the parameters reported by the Quantra System with the QPlus Cartridge in pediatric patients.

Eligibility criteria

Qualifiers

Subject is <18 years of age

Corrected gestational age ≥ 37weeks

Subject is scheduled for an elective surgery, non-surgical intervention or diagnostic procedure requiring anesthesia and vascular access with an ASA score ≤3.

Subject's parent or guardian has signed an informed consent form. If required, subject has signed an assent form.

Disqualifiers

Subject is hospitalized in the Pediatric Intensive Care Unit

Subject requires Extracorporeal Membrane Oxygenation (ECMO)

Subject has had an infection within 7 days of the scheduled procedure

Subject has an active coagulation disorder (bleeding or thrombosis)

Trial design

Treatments tested in this trial

  • Quantra System

Treatment groups

240 Participants
are divided into 1 treatment group

Sponsors and collaborators